L04AA26

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
49	全身性エリテマトーデス	11

49. 全身性エリテマトーデス

臨床試験数 : 993 / 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200

trials per page:

Showing 1 to 10 of 11 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2011-005667-25-PL (EUCTR)	22/05/2014	07/06/2013	Belimumab Assessment of Safety in SLE (BASE)	A Randomized, Double-Blind, Placebo-Controlled 52-Week Studyto Assess Adverse Events of Special Inte ...	Lupus Erythematosus MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: Systemic lupus ...	Trade Name: Benlysta 400 mg powder for concentrate for solution for infusion Product Name: Belimumab P ...	Human Genome Sciences Inc. (a wholly owned subsidiary of GlaxoSmithKline PLC)	NULL	Not Recruiting			Female: yes Male: yes	4000	Phase 4	United States;Serbia;Portugal;Philippines;Taiwan;Hong Kong;Estonia;Slovakia;Thailand;Spain;Ukraine;I ...
2	EUCTR2011-005667-25-RO (EUCTR)	21/06/2013	21/07/2014	Belimumab Assessment of Safety in SLE (BASE)	A Randomized, Double-Blind, Placebo-Controlled 52-Week Studyto Assess Adverse Events of Special Inte ...	Lupus Erythematosus MedDRA version: 17.0;Level: PT;Classification code 10042945;Term: Systemic lupus ...	Trade Name: Benlysta 400 mg powder for concentrate for solution for infusion Product Name: Belimumab P ...	Human Genome Sciences Inc. (a wholly owned subsidiary of GlaxoSmithKline PLC)	NULL	Not Recruiting			Female: yes Male: yes	5000	Phase 4	United States;Serbia;Portugal;Philippines;Taiwan;Hong Kong;Estonia;Slovakia;Thailand;Spain;Ukraine;I ...
3	EUCTR2011-005672-42-GB (EUCTR)	11/06/2013	27/03/2013	Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE) (EMB ...	A Phase 3/4, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate t ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 19.1;Level: LLT;Classification code 10025134;Term ...	Trade Name: Benlysta 400 mg powder for concentrate for solution for infusion Product Name: Belimumab P ...	Human Genome Sciences, Inc. (a wholly owned subsidiary of GlaxoSmithKline PLC)	NULL	Not Recruiting			Female: yes Male: yes	501	Phase 3;Phase 4	United States;France;Martinique;Brazil;South Africa;Colombia;United Kingdom
4	EUCTR2011-005667-25-LT (EUCTR)	10/05/2013	29/11/2012	Belimumab Assessment of Safety in SLE (BASE)	A Randomized, Double-Blind, Placebo-Controlled 52-Week Studyto Assess Adverse Events of Special Inte ...	Lupus Erythematosus MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: Systemic lupus ...	Trade Name: Benlysta 400 mg powder for concentrate for solution for infusion Product Name: Belimumab P ...	GlaxoSmithKline, LLC	NULL	Not Recruiting			Female: yes Male: yes	4000	Phase 4	Portugal;Serbia;United States;Philippines;Estonia;Hong Kong;Taiwan;Slovakia;Spain;Thailand;Ukraine;I ...
5	EUCTR2011-005667-25-BG (EUCTR)	24/04/2013	31/01/2013	Belimumab Assessment of Safety in SLE (BASE)	A Randomized, Double-Blind, Placebo-Controlled 52-Week Studyto Assess Adverse Events of Special Inte ...	Lupus Erythematosus MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: Systemic lupus ...	Trade Name: Benlysta 400 mg powder for concentrate for solution for infusion Product Name: Belimumab P ...	GlaxoSmithKline, LLC	NULL	Not Recruiting			Female: yes Male: yes	4000	Phase 4	Portugal;Serbia;United States;Philippines;Estonia;Hong Kong;Taiwan;Slovakia;Spain;Thailand;Ukraine;I ...
6	EUCTR2011-005667-25-PT (EUCTR)	05/04/2013	17/01/2013	Belimumab Assessment of Safety in SLE (BASE)	A Randomized, Double-Blind, Placebo-Controlled 52-Week Studyto Assess Adverse Events of Special Inte ...	Lupus Erythematosus MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: Systemic lupus ...	Trade Name: Benlysta 400 mg powder for concentrate for solution for infusion Product Name: Belimumab P ...	GlaxoSmithKline, LLC	NULL	Not Recruiting			Female: yes Male: yes	4000	Phase 4	Portugal;Serbia;United States;Philippines;Estonia;Hong Kong;Taiwan;Slovakia;Spain;Thailand;Ukraine;I ...
7	EUCTR2011-005667-25-SK (EUCTR)	27/03/2013	05/02/2013	Belimumab Assessment of Safety in SLE (BASE)	A Randomized, Double-Blind, Placebo-Controlled 52-Week Studyto Assess Adverse Events of Special Inte ...	Lupus Erythematosus MedDRA version: 20.0;Level: PT;Classification code 10042945;Term: Systemic lupus ...	Trade Name: Benlysta 400 mg powder for concentrate for solution for infusion Product Name: Belimumab P ...	Human Genome Sciences Inc. (a wholly owned subsidiary of GlaxoSmithKline PLC)	NULL	Not Recruiting			Female: yes Male: yes	4000	Phase 4	United States;Serbia;Portugal;Philippines;Taiwan;Hong Kong;Estonia;Slovakia;Thailand;Spain;Ukraine;I ...
8	EUCTR2011-005667-25-ES (EUCTR)	14/02/2013	21/12/2012	Belimumab Assessment of Safety in SLE (BASE)	A Randomized, Double-Blind, Placebo-Controlled 52-Week Studyto Assess Adverse Events of Special Inte ...	Lupus Erythematosus MedDRA version: 14.1;Level: PT;Classification code 10042945;Term: Systemic lupus ...	Trade Name: Benlysta 400 mg powder for concentrate for solution for infusion Product Name: Belimumab P ...	Human Genome Sciences Inc. (a wholly owned subsidiary of GlaxoSmithKline PLC)	NULL	Not Recruiting			Female: yes Male: yes	5000	Phase 4	United States;Serbia;Portugal;Philippines;Taiwan;Hong Kong;Estonia;Slovakia;Thailand;Spain;Ukraine;I ...
9	EUCTR2011-005667-25-CZ (EUCTR)	30/01/2013	04/12/2012	Belimumab Assessment of Safety in SLE (BASE)	A Randomized, Double-Blind, Placebo-Controlled 52-Week Studyto Assess Adverse Events of Special Inte ...	Lupus Erythematosus MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: Systemic lupus ...	Trade Name: Benlysta 400 mg powder for concentrate for solution for infusion Product Name: Belimumab P ...	GlaxoSmithKline, LLC	NULL	Not Recruiting			Female: yes Male: yes	4000	Phase 4	Portugal;Serbia;United States;Philippines;Estonia;Hong Kong;Taiwan;Slovakia;Spain;Thailand;Ukraine;I ...
10	EUCTR2011-005667-25-HU (EUCTR)	22/01/2013	22/11/2012	Belimumab Assessment of Safety in SLE (BASE)	A Randomized, Double-Blind, Placebo-Controlled 52-Week Studyto Assess Adverse Events of Special Inte ...	Lupus Erythematosus MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: Systemic lupus ...	Trade Name: Benlysta 400 mg powder for concentrate for solution for infusion Product Name: Belimumab P ...	GlaxoSmithKline, LLC	NULL	Not Recruiting			Female: yes Male: yes	4000	Phase 4	Portugal;Serbia;United States;Philippines;Estonia;Hong Kong;Taiwan;Slovakia;Spain;Thailand;Ukraine;I ...

First Previous1 2Next Last